TOP STORIES

• REGULATORY Japan Approves Mefeego as First Abortion Pill
  May 1, 2023

• REGULATORY Outline of Expert Panel Report Calls for New Forum to Discuss Generics’ Future, Revisiting of Spillover Rule
  April 28, 2023

• BUSINESS 374 Chugai Employees Apply for Voluntary Redundancy Program
  April 28, 2023

• ACADEMIA More Japan-Specific Data, Stable Supplies of Pfizer’s Stelues Needed amid Syphilis Surge: Specialist
  April 27, 2023

• BUSINESS Lilly Japan Suffers Negative Growth for 3rd Straight Year in 2022 as 2 Major LOEs Weigh
  April 26, 2023

• BUSINESS Sumitomo Curbs Shipments of Diabetes Hopeful Twymeeg on More-Than-Expected Demands
  April 25, 2023

• REGULATORY Health Ministry Panel OKs Japan’s First Abortion Pill with Official Go-Ahead Set for May
  April 24, 2023

• BUSINESS Drug Makers’ New Grad Hiring in Japan Up 5.8%, Rising for 1st Time since FY2020
  April 21, 2023

• BUSINESS Nippon BI Logs 4% Growth on NHI Price-Based Sales; Jardiance, Ofev as Engines
  April 21, 2023

• ACADEMIA Abortion Pill Is Beneficial as New Option, but Don’t See It as Easy Solution: OB/GYN Association Chair
  April 20, 2023

• REGULATORY Japan to End Priority Review for COVID Drugs and Vaccines after Severity Downgrade: Official
  April 20, 2023

• BUSINESS Ono Aims Higher with Aggressive Open Innovation in Drug Discovery
  April 19, 2023

• BUSINESS Lilly’s Mounjaro Hits Japan Pharmacy Shelves, Mitsubishi as Distributor
  April 19, 2023

• REGULATORY LDP Gathers Steam towards Pharma Policy Proposal Next Month, Sees Honebuto as Make-or-Break Milestone
  April 18, 2023

• REGULATORY Abortion Pill Mefeego’s Japan Panel Review Rescheduled for April 21
  April 18, 2023

• ORGANIZATION Pharma CEOs Call for Japan’s Leadership to Tackle Global Health Issues at G7 Summit
  April 17, 2023

• ORGANIZATION Japan, US, EU Trade Groups Push Price Maintenance during Patent Period: Joint Statement
  April 17, 2023

• BUSINESS AstraZeneca Japan Grows 17% in 2022, Bags 12 Approvals; Up to 7 Filings Eyed for 2023
  April 14, 2023

• BUSINESS Axcelead to Expand Overseas Biz, Shoots for 130 Billion Yen Sales and 5,000-Plus Researchers
  April 13, 2023

• REGULATORY Lawmakers Split 50/50 on Abortion Pill, No Conclusion at LDP Panel
  April 13, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 62
• 63
• 64
• 65
• 66
• 67
• 68
• 69
• 70
• …
• Next ›
• 最終 »